ArticleSocial psychiatry and psychiatric epidemiology2025
Prospective prediction of first onset of major depressive disorder in midlife using machine learning.
Article in Social psychiatry and psychiatric epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeIn this paper we leverage machine learning (ML) models to prospectively predict the first onset of Major Depressive Disorder (MDD), one of the most common and disabling mental health conditions. While such prediction models hold potential for enabling early interventions, few studies have applied ML approaches to this task, and those that have are heterogeneous in nature. Moreover, the clinical utility of these predictive models remains largely unexamined.
methodsData stemmed from CoLaus|PsyCoLaus, a population-based cohort study. In total, 1350 participants, age 35-66 years without lifetime MDD at baseline participated in the physical and psychiatric baseline and at least one psychiatric follow-up evaluation. Models based on logistic regression, elastic net, random forests, and XGBoost were trained using an extensive array of psychosocial, environmental, biological, and genetic predictors. Discriminative performance, calibration, clinical utility, and individual predictor contributions were assessed using nested cross-validation.
resultsDiscriminative performance was comparable between models (areas under the precision-recall curve between 0.36 and 0.38; areas under the receiver operating characteristic curve between 0.65 and 0.68). Decision curve analysis suggested clinical utility of logistic regression, elastic net, and random forests for threshold probabilities between 10% and 40%. Across all models, neuroticism, sex, and age were the most important predictors.
conclusionsAlthough the prediction models achieved discriminative performance levels above chance, further refinement is necessary. The addition of biological and genetic predictors did not elevate performance markedly. Additional research seems warranted given the limited number and heterogeneous nature of existing studies, the burden associated with MDD, and the potential to improve overall outcomes for people at risk for MDD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.